Home › Prostate Cancer › NCT06960798

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (Nat-Geno)

Who can join

Ages 18 to 100 · Men

Inclusion Criteria:

* Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
* At least 18 years-of-age at the time of signature of the informed consent form (ICF).
* Patients who self-identify as Native American.
* Patients with a pathologically proven diagnosis of PC (any stage).
* Availability of most recent archived tumor samples.

Exclusion Criteria:

* Patients not of Native American descent or identity.
* Patient does not have archival tissue available.

About the study

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

What is being tested

• Bio-specimen Collection (other)
• Blood Draw (other)

Sponsor: University of Oklahoma · Participants: 150 · Started: Oct 2, 2026

Contact the study team

• Lead Onco Nurse · Phone: 405-271-8777
• Adanma Ayanambakkam, MD · Phone: 405-271-4022

Official record on ClinicalTrials.gov — NCT06960798

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.